Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose acetylsalicylic acid for primary cardiovascular prevention in chronic kidney disease (AASER)
2009-013437-21Phase 4Active
- Sponsor
- José Luño Fernandez
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of aspirin in cardiac morbidity and major adverse cardiac events (MACE), sponsored by José Luño Fernandez. Primary endpoint: Primary composite cardiovascular endpoint. Started Feb 2010; status: active.
02
Drugs
aspirin
03
Conditions
cardiac morbiditymajor adverse cardiac events (MACE)
Beyond the preview
Go deeper on 2009-013437-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013437-21.